Dataset Information

Identification and Validation of Novel Diagnostic Biomarkers for Keloid Based on GEO Database

ABSTRACT:

Introduction

Keloid is a pathological scar type, which invades normal surrounding tissue without self-limiting to cause pain, itching, cosmetic disfigurement, etc. Knowledge of the molecular mechanisms underlying keloid remains unclear. This dilemma leads to no biomarker available for diagnosis. Thus, to seek accurate diagnosis, biomarkers are necessary for keloid diagnosis to help control its incidence.

Methods

Gene Expression Omnibus (GEO) database was used to select differentially expressed miRNAs (DE-miRNAs) in GSE113620. miRTarBase miRNA–target tools were used to predict the interactions between miRNAs and their target mRNAs. Target mRNAs that were differentially expressed in keloid were selected by analyzing differentially expressed genes (DEGs) in GSE44270 and GSE92566. PPI network analysis, gene enrichment analysis, cell-specific and tissue-specific expression analyses of DE-target mRNAs were conducted. RT-PCR analysis was conducted to validate our results.

Results

Three novel miRNAs (miR-30b-5p, miR-212-3p, miR-149-5p) and five target mRNAs (SIX1, CCNA2, CCNB1, FOXM1, RUNX2) were identified as potential biomarkers for keloid patients. Additionally, the potential functions of those miRNAs-mRNAs pathways were analyzed.

Discussion

These findings of keloid-related miRNAs, mRNAs, and miRNA–mRNAs regulatory networks may provide insights into the underlying pathogenesis of keloid and serve as potential biomarkers for keloid diagnosis.

SUBMITTER: Nurzati Y

PROVIDER: S-EPMC8801514 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:BackgroundThe molecular biological mechanisms underlying heart failure (HF) remain poorly understood. Therefore, it is imperative to use innovative approaches, such as high-throughput sequencing and artificial intelligence, to investigate the pathogenesis, diagnosis, and potential treatment of HF.MethodsFirst, we initially screened Two data sets (GSE3586 and GSE5406) from the GEO database containing HF and control samples from the GEO database to establish the Train group, and selected another dataset (GSE57345) to construct the Test group for verification. Next, we identified the genes with significantly different expression levels in patients with or without HF and performed functional and pathway enrichment analyses. HF-specific genes were identified, and an artificial neural network was constructed by Random Forest. The ROC curve was used to evaluate the accuracy and reliability of the constructed model in the Train and Test groups. Finally, immune cell infiltration was analyzed to determine the role of the inflammatory response and the immunological microenvironment in the pathogenesis of HF.ResultsIn the Train group, 153 significant differentially expressed genes (DEGs) associated with HF were found to be abnormal, including 81 down-regulated genes and 72 up-regulated genes. GO and KEGG enrichment analyses revealed that the down-regulated genes were primarily enriched in organic anion transport, neutrophil activation, and the PI3K-Akt signaling pathway. The upregulated genes were mainly enriched in neutrophil activation and the calcium signaling. DEGs were identified using Random Forest, and finally, 16 HF-specific genes were obtained. In the ROC validation and evaluation, the area under the curve (AUC) of the Train and Test groups were 0.996 and 0.863, respectively.ConclusionsOur research revealed the potential functions and pathways implicated in the progression of HF, and designed an RNA diagnostic model for HF tissues using machine learning and artificial neural networks. Sensitivity, specificity, and stability were confirmed by ROC curves in the two different cohorts.